Dr. LILIAN RICCIO | Diagnosis | Best Researcher Award

Posted on by Pencis

Dr. LILIAN RICCIO | Diagnosis | Best Researcher Award

FIOCRUZ | Brazil.

Author Profile

Scopus

Orcid ID

🎓EARLY ACADEMIC PURSUITS

Dr. Lilian Riccio embarked on her academic journey with a strong foundation in Medical Sciences, demonstrating a profound interest in Infectious Diseases and Diagnostics from an early stage. She pursued her undergraduate studies in Microbiology and Immunology, excelling in research that laid the groundwork for her future contributions to the field. Driven by an insatiable curiosity, she obtained her Doctorate in Infectious Disease Research, focusing on advanced diagnostic methodologies to combat emerging pathogens.

💼PROFESSIONAL ENDEAVORS

With a career spanning decades, Dr. Riccio has held esteemed positions in top-tier research institutions and healthcare organizations. She has led clinical research laboratories, spearheaded public health initiatives, and collaborated with global health agencies to refine infectious disease diagnostic techniques. Her tenure as a senior infectious disease specialist has significantly influenced policy-making and disease control strategies worldwide.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON DIAGNOSIS

Dr. Riccio’s pioneering work revolves around early detection and precise diagnosis of infectious diseases. She has developed innovative molecular diagnostic tools, enhancing the speed and accuracy of pathogen identification. Her research has focused on rapid testing methodologies, biomarker discovery, and next-generation sequencing technologies. These advancements have transformed the way medical professionals approach disease outbreaks and patient treatment protocols.

🌍IMPACT AND INFLUENCE

Dr. Riccio’s work has had a global impact, particularly in regions affected by epidemics and emerging infectious threats. Her collaborations with World Health Organizations, Centers for Disease Control, and leading universities have played a crucial role in shaping public health policies. She has contributed extensively to disease surveillance programs, influencing the standardization of diagnostic techniques across various healthcare systems.

📚ACADEMIC CITATIONS

Dr. Riccio has authored numerous peer-reviewed articles, with her work cited extensively in top medical journals such as The Lancet, Journal of Infectious Diseases, and Clinical Microbiology Reviews. Her publications have served as foundational references for researchers and clinicians in the field of infectious disease diagnostics and epidemiology.

🏆RESEARCH GRANTS AND FUNDING

Recognized for her exceptional contributions, Dr. Riccio has secured multiple research grants from prestigious organizations, including:

  • National Institutes of Health (NIH)
  • Bill & Melinda Gates Foundation
  • European Research Council (ERC)
  • World Health Organization (WHO) These funding sources have enabled her to drive cutting-edge research, particularly in low-resource settings, ensuring equitable access to advanced diagnostic tools.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Dr. Riccio’s legacy is built on her relentless pursuit of innovation in infectious disease diagnostics. Her future projects aim to integrate AI-driven diagnostic models, ensuring real-time detection and response to pandemic threats. She continues to mentor young scientists, fostering the next generation of infectious disease experts.

🌟A VISIONARY IN INFECTIOUS DISEASES

Dr. Lilian Riccio stands as a visionary leader in the realm of infectious disease diagnostics and global health. Her unwavering dedication to enhancing diagnostic precision and accessibility has redefined the landscape of disease detection and prevention. As she continues her groundbreaking research, her impact remains unparalleled, shaping the future of infectious disease management worldwide.

📑NOTABLE PUBLICATIONS

Novel isothermal nucleic acid amplification method for detecting malaria parasites

Authors: Lucas Tavares de Queiroz, Barbara Oliveira Baptista, Rebecca de Abreu-Fernandes, Cláudio Tadeu Daniel-Ribeiro, Lilian Rose Pratt-Riccio

Year: 2024

Journal: Applied Microbiology and Biotechnology

Characterization of T and B cell epitopes in PvCyRPA by studying the naturally acquired immune response in Brazilian Amazon communities

Authors: Isabela Ferreira Soares, Barbara de Oliveira Baptista, Ada da Silva Matos, Lilian Rose Pratt-Riccio, Josué da Costa Lima-Junior

Year: 2024

Journal: Scientific Reports

Profile of metacaspase gene expression in Plasmodium vivax field isolates from the Brazilian Amazon

Authors: Carolina Moreira Blanco, Hugo Amorim Dos Santos de Souza, Priscilla Da Costa Martins, Cláudio Tadeu Daniel-Ribeiro, Paulo Renato Rivas Totino

Year: 2024

Journal: Molecular Biology Reports

Dynamics of IgM and IgG Antibody Response Profile against Linear B-Cell Epitopes from Exoerythrocytic (CelTOS and TRAP) and Erythrocytic (CyRPA) Phases of Plasmodium vivax: Follow-Up Study

Authors: Cinthia Magalhães Rodolphi, Isabela Ferreira Soares, Ada Da Silva Matos, K. K.G. Scopel, Josué da Costa Lima-Junior

Year: 2024

Journal: Antibodies

Cell Death of P. vivax Blood Stages Occurs in Absence of Classical Apoptotic Events and Induces Eryptosis of Parasitized Host Cells

Authors: Carolina Moreira Blanco, Hugo Amorim dos Santos de Souza, Priscilla Martins, Juliana Almeida-Silva, Ana Marcia Suarez-Fontes, Yury Oliveira Chaves, Marcos André Vannier-Santos, Lilian Pratt-Riccio, Cláudio Tadeu Daniel-Ribeiro, Stefanie Costa Pinto Lopes, et al.

Year: 2024

Journal: Pathogens

Mr. Xiangao Jiang | Infectious Diseases Prevention | Best Researcher Award

Posted on by Pencis

Mr. Xiangao Jiang | Infectious Diseases Prevention | Best Researcher Award

Wenzhou Sixth People’s Hospital | China.

Author Profile

Scopus

🎓Education

Master’s Degree – Wenzhou Medical College

💼Professional Experience

Mr. Jiang has held several key leadership positions in the healthcare sector. He serves as the Deputy Secretary of the Party Committee at Wenzhou Central Hospital and previously led as the President of the Sixth People’s Hospital of Wenzhou. During the COVID-19 pandemic, he played a critical role as the Leader of the COVID-19 Treatment Team in Wenzhou, ensuring effective patient care and outbreak control. Additionally, he led the Wenzhou Medical Team in Shanghai, where he also served as the Temporary Party Branch Secretary, overseeing medical operations and emergency response efforts.

📚Academic Contributions

Mr. Jiang has made significant contributions to medical research, with 17+ SCI-indexed publications and over 30 articles in Chinese medical journals. He has also served as an editor of two medical books, further advancing knowledge in infectious disease management. His research efforts extend to national and provincial projects, where he has played a key role in developing innovative healthcare solutions and public health strategies.

🧑‍🔬Technical Skills 

Mr. Xiangao Jiang possesses advanced expertise in infectious disease diagnosis and treatment, specializing in managing hepatitis, chronic liver diseases, tuberculosis, and other critical infections. His proficiency extends to critical care management, where he has played a key role in handling complex and severe infectious disease cases. Additionally, his strong leadership in medical administration and public health response has been demonstrated through his roles in hospital management, pandemic control, and policy implementation, ensuring effective healthcare delivery and crisis management.

📚Teaching Experience

Tutor for postgraduate students at Wenzhou Medical University & Shanghai University

🏆Awards and Honors

Mr. Jiang’s outstanding contributions to medicine and healthcare have earned him the prestigious titles of Wenzhou Famous Doctor and Ou Yue Famous Doctor. His leadership and expertise have also been recognized through his selection as a Health Leading Talent under Zhejiang Province’s “Ten Thousand People Plan”, a distinction awarded to top professionals making significant impacts in their fields.

🔬Research Interests

Mr. Jiang’s research focuses on hepatitis and chronic liver diseases, with an emphasis on understanding disease progression and developing effective treatment strategies. He is also deeply engaged in infectious disease epidemiology, studying patterns and risk factors to enhance prevention and control measures. Additionally, his work in public health and outbreak management has contributed to improving emergency response strategies and healthcare policies, particularly in the face of emerging infectious threats.

📑Notable Publications 

‘Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China’
Authors: C. Qiu, Chaochao; X. Lin, Xiaoqing; Q. Zhang, Qiang; J. Shi, Jichan; X. Jiang, Xiangao
Year: 2025
Journal: BMC Infectious Diseases

‘Risk factors for multidrug resistance in pulmonary tuberculosis patients with diabetes mellitus’
Authors: L. Wu, Lianpeng; N. Chen, Na; D. Xia, Dandan; X. Jiang, Xiangao
Year: 2025
Journal: Frontiers in Medicine

 ‘Drug resistance in drug-resistant tuberculosis patients with and without diabetes mellitus: a comparative analysisy’
Authors: X. Cai, Xiaoxiao; X. Xu, Xueqin; G. He, Guiqing; X. Jiang, Xiangao; L. Wu, Lianpeng
Year: 2024
Journal: BMC Infectious Diseases

‘Discordant results between Xpert MTB/RIF assay and Bactec MGIT 960 culture system regarding the detection of rifampin-resistant Mycobacterium tuberculosis isolates in Wenzhou, China‘

Authors: G. He, Guiqing; Q. Zheng, Qingyong; J. Wu, Jing; X. Jiang, Xiangao; X. Yu, Xia
Year: 2024
Journal: Microbiology Spectrum

Mrs. Hongmei Ding | Cerebrovascular Disease | Best Researcher Award

Posted on by Pencis

Mrs. Hongmei Ding | Cerebrovascular Disease | Best Researcher Award

Affiliated Hospital of Xuzhou Medical University | China.

Author Profile

Scopus

🎓Education

Dr. Ding Hongmei earned her Ph.D. in Neurology from Nanjing Medical University (2016–2023), where she focused on cerebrovascular disorders and stroke mechanisms, contributing valuable research to the field. Prior to this, she completed her Master’s Degree in Neurology at Xuzhou Medical University (2011–2014), specializing in stroke biomarkers and treatment approaches, which enhanced her expertise in diagnosing and managing stroke-related conditions. Her academic journey began with a Bachelor’s Degree in Clinical Medicine from Xuzhou Medical University (2001–2006), where she built a strong foundation in neurological sciences and clinical practice, shaping her path toward a distinguished career in neurology.

💼Professional Experience

Dr. Ding Hongmei has been serving as a Senior Neurologist at the Affiliated Hospital of Xuzhou Medical University (2014–Present), where she leads neurological care, stroke treatment, and medical education, playing a pivotal role in patient management and mentoring future medical professionals. Before this, she worked as a Neurologist at Huai’an Fourth People’s Hospital (2006–2011), where she gained hands-on experience in stroke management and acute neurology, refining her clinical expertise. Additionally, she actively participated in COVID-19 response efforts at Suining Fangcang Hospital (2022, 1 month), contributing to public health and emergency response during a critical time.

📚Academic Contributions

Dr. Ding Hongmei has played a pivotal role in stroke and neurology research, contributing to major clinical trials such as CATIS, CHANCE, TASTE, and BAST, which focus on stroke prevention and treatment. She has been actively involved in new drug development trials and has led studies on blood pressure management in acute stroke under the National Stroke Prevention Project. Additionally, her research with the Jiangsu Provincial Natural Science Foundation has advanced the understanding of ischemia-reperfusion injury mechanisms.

🧑‍🔬Technical Skills 

✅ Neurological diagnostics – Stroke assessment, cerebrovascular imaging, and biomarkers
✅ Clinical trials & research – Extensive involvement in drug trials for stroke treatment
✅ Medical education – Development of innovative teaching models for neurology

📚Teaching Experience

Dr. Ding is an advocate for modern medical education and has published research on:
📌 Online and multimodal teaching methods in neurology education
📌 Integration of digital learning in medical training

🏆Awards and Honors

🏅 Recipient of research grants from the Jiangsu Provincial Natural Science Foundation
🏅 Recognized contributor to the National Stroke Prevention Project
🏅 Key investigator in leading stroke prevention clinical trials

🔬Research Interests

Dr. Ding is deeply invested in stroke prevention, ischemic brain injury, and neuroprotection. Her focus areas include:
🔹 Early intervention strategies for stroke patients
🔹 Biomarker discovery for neurological disorders
🔹 Neurorehabilitation and cognitive recovery techniques
🔹 Medical education innovations to enhance neurology training

📑Notable Publications 

‘Identification of Specific Risk Factors and Predictive Analytics for Cardio-Cerebral Arterial Stenosis: A Comparative Study Utilizing Framingham Risk Stratification Insights’
Authors: Zhang G., Dong S., Feng F., Ding H., Dong R.
Year: 2025
Journal: BMC Neurology

‘Clinical Epidemiological Characteristics of Nitrous Oxide Abusers: A Single-Center Experience in a Hospital in China’
Authors: Li Y., Dong J., Xu R., Feng F., Kan W., Ding H., Wang X., Chen Y., Wang X., Zhu S., Dong R.
Year: 2021
Journal: Brain and Behavior

 ‘1α,25-Dihydroxyvitamin D3 Promotes Angiogenesis After Cerebral Ischemia Injury in Rats by Upregulating the TGF-β/Smad2/3 Signaling Pathway’
Authors: Zhang Y., Mu Y., Ding H., Du B., Zhou M., Li Q., Gong S., Zhang F., Geng D., Wang Y.
Year: 2022
Journal: Frontiers in Cardiovascular Medicine

‘Diprotin A TFA Exerts Neurovascular Protection in Ischemic Cerebral Stroke’
Authors: Zhou M.Y., Zhang Y.J., Ding H.M., Wu W.F., Cai W.W., Wang Y.Q., Geng D.Q.
Year: 2022
Journal: Frontiers in Neuroscience

‘Nrf2 Protects Against Cerebral Ischemia-Reperfusion Injury by Suppressing Programmed Necrosis and Inflammatory Signaling Pathways’
Authors: Chen W., Teng X., Ding H., Xie Z., Cheng P., Liu Z., Feng T., Zhang X., Huang W., Geng D.
Year: 2022
Journal: Annals of Translational Medicine